Recall: Children's Panadol 5-12 years suspension 200 mL bottle

 
GlaxoSmithKline Consumer Healthcare Australia, in consultation with the TGA, is in the process of recalling three batches of Children's Panadol 5-12 years suspension, supplied in 200 mL bottles.

It has been identified that an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres. The quantity of these particles would be small and they may not be visible in the product. If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.

The affected batch numbers are:
  •  136418 (strawberry flavour)
  • 136444 (strawberry flavour)
  • 136443 (orange flavour)

The expiry date for each of the recalled products is February 2018.

The batch number and expiry date are located at the bottom of the bottle label and embossed on the base of the outer box.

No other batches, bottle sizes or products are affected by this recall.
Copyright © Australian and New Zealand College of Anaesthetists.